Page 12 - Engager Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Innate Pharma SA: Number of Shares and Voting Rights of Innate Pharma as of July 1, 2023

Innate Pharma SA: Number of Shares and Voting Rights of Innate Pharma as of July 1, 2023
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Henry wheelerArthur rouillCompany annual report on formExchange commissionFrench financial markets authorityDes marchGeneral regulationInnate pharmaEuronext parisEngager therapeuticsPrivate securities litigation reform actRisk factorsUniversal registration documentAnnual reportIhre watchlist

Number of Shares and Voting Rights of Innate Pharma as of July 1, 2023

Number of Shares and Voting Rights of Innate Pharma as of July 1, 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Henry wheelerArthur rouillFrench financial markets authorityCompany annual report on formExchange commissionDes marchGeneral regulationInnate pharmaEuronext parisEngager therapeuticsPrivate securities litigation reform actRisk factorsUniversal registration documentAnnual report

Innate Pharma: First Patient Dosed in Phase 2 MATISSE Trial of IPH5201 in Early Stage Lung Cancer

Innate Pharma: First Patient Dosed in Phase 2 MATISSE Trial of IPH5201 in Early Stage Lung Cancer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

France generalGustave roussyFabrice barlesiHenry wheelerArthur rouillJoyson karakunnelParis saclay universityFrench financial markets authorityExchange commissionCompany annual report on formEuronext parisInnate pharmaChief medical officerGeneral managerInnate pharma astrazeneca multi term agreementEngager therapeutics

Innate Pharma (IPHA) Highlights Increased Lacutamab Clinical Activity From Interim Results of Phase 2 TELLOMAK Study

Innate Pharma (IPHA) Highlights Increased Lacutamab Clinical Activity From Interim Results of Phase 2 TELLOMAK Study
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesPierluigi porcuHenry wheelerJoyson karakunnelArthur rouillFrench financial markets authorityDrug administrationJefferson healthSidney kimmel cancer centerCompany annual report on formEuropean medicines agencyEuropean unionDivision of hematologic malignanciesInternational conference on malignant lymphomaExchange commissionInnate pharma

Innate Pharma SA: Innate Pharma Highlights Increased Lacutamab Clinical Activity From Interim Results of Phase 2 TELLOMAK Study With Updated Olsen Criteria

Innate Pharma SA: Innate Pharma Highlights Increased Lacutamab Clinical Activity From Interim Results of Phase 2 TELLOMAK Study With Updated Olsen Criteria
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesHenry wheelerPierluigi porcuArthur rouillJoyson karakunnelEuropean medicines agencyDivision of hematologic malignanciesInternational conference on malignant lymphomaJefferson healthDrug administrationExchange commissionSidney kimmel cancer centerFrench financial markets authorityEuropean unionCompany annual report on formInternational conference